2018
Overview
Antimicrobial chemotherapy is the use of drugs to prevent, control, or eliminate infections caused by microorganisms such as bacteria, fungi, viruses, and parasites. It encompasses distinct drug classes, including antibacterials (antibiotics), antifungals, antivirals, and antiparasitics, each designed to interfere with processes essential to the pathogen while sparing the host. Effective antimicrobial chemotherapy depends on accurate identification of the causative organism, appropriate drug selection, correct dosing and duration, and consideration of pharmacokinetics, toxicity, and the growing challenge of antimicrobial resistance. The discipline also addresses prophylactic use, combination regimens to broaden coverage or limit resistance, and stewardship strategies that preserve the long-term effectiveness of available agents. As a central pillar of modern medicine, antimicrobial chemotherapy underpins the treatment of community- and hospital-acquired infections and supports interventions such as surgery, chemotherapy, and transplantation that increase susceptibility to infection. This page, within the International Journal of Chemotherapy Research and Practice, gathers peer-reviewed, open-access scholarship relevant to chemotherapeutic and therapeutic research, providing a reference point for readers interested in the principles and applications of antimicrobial treatment.
Research published in this journal
1 peer-reviewed article, ranked by relevance. Each links to its DOI.